Regal Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,573
| Closed | -$219K | – | 664 |
|
|
2026
Q1 | $219K | Buy |
+1,573
| New | +$220K | 0.01% | 614 |
|
|
2024
Q1 | – | Sell |
-3,818
| Closed | -$309K | – | 589 |
|
|
2023
Q4 | $309K | Sell |
3,818
-135
| -3% | -$10.5K | 0.02% | 415 |
|
|
2023
Q3 | $296K | Buy |
3,953
+66
| +2% | +$5.08K | 0.02% | 393 |
|
|
2023
Q2 | $300K | Sell |
3,887
-8
| -0.2% | -$638 | 0.03% | 396 |
|
|
2023
Q1 | $323K | Buy |
3,895
+277
| +8% | +$22.9K | 0.03% | 369 |
|
|
2022
Q4 | $311K | Sell |
3,618
-18,638
| -84% | -$1.48M | 0.03% | 370 |
|
|
2022
Q3 | $1.37M | Buy |
22,256
+461
| +2% | +$29.1K | 0.14% | 143 |
|
|
2022
Q2 | $1.35M | Sell |
21,795
-581
| -3% | -$36K | 0.14% | 146 |
|
|
2022
Q1 | $1.33M | Buy |
22,376
+1,263
| +6% | +$80.7K | 0.12% | 167 |
|
|
2021
Q4 | $1.53M | Buy |
21,113
+3,661
| +21% | +$252K | 0.14% | 155 |
|
|
2021
Q3 | $1.22M | Buy |
17,452
+3,432
| +24% | +$241K | 0.12% | 188 |
|
|
2021
Q2 | $965K | Buy |
+14,020
| New | +$936K | 0.1% | 228 |
|
|
2021
Q1 | – | Sell |
-17,220
| Closed | -$1M | – | 187 |
|
|
2020
Q4 | $1M | Buy |
+17,220
| New | +$1.04M | 0.11% | 178 |
|
|
2020
Q3 | – | Sell |
-19,673
| Closed | -$1.51M | – | 95 |
|
|
2020
Q2 | $1.51M | Buy |
+19,673
| New | +$1.51M | 0.28% | 92 |
|
|
2020
Q1 | – | Sell |
-29,373
| Closed | -$1.91M | – | 132 |
|
|
2019
Q4 | $1.91M | Sell |
29,373
-433
| -1% | -$28.2K | 0.34% | 95 |
|
|
2019
Q3 | $1.89M | Buy |
+29,806
| New | +$1.95M | 0.37% | 91 |
|
|
2018
Q4 | – | Sell |
-3,105
| Closed | -$240K | – | 344 |
|
|
2018
Q3 | $240K | Buy |
+3,105
| New | +$235K | 0.05% | 274 |
|
|
2018
Q2 | – | Sell |
-2,719
| Closed | -$205K | – | 276 |
|
|
2018
Q1 | $205K | Buy |
+2,719
| New | +$216K | 0.05% | 298 |
|
|
2017
Q4 | – | Sell |
-2,945
| Closed | -$239K | – | 296 |
|
|
2017
Q3 | $239K | Buy |
2,945
+26
| +0.9% | +$1.99K | 0.06% | 242 |
|
|
2017
Q2 | $207K | Sell |
2,919
-25,159
| -90% | -$1.67M | 0.05% | 246 |
|
|
2017
Q1 | $1.91M | Sell |
28,078
-4,121
| -13% | -$290K | 0.5% | 70 |
|
|
2016
Q4 | $2.31M | Sell |
32,199
-1,290
| -4% | -$95.9K | 0.64% | 59 |
|
|
2016
Q3 | $2.65M | Sell |
33,489
-1,229
| -4% | -$99.8K | 0.75% | 50 |
|
|
2016
Q2 | $2.9M | Sell |
34,718
-641
| -2% | -$56.9K | 0.8% | 42 |
|
|
2016
Q1 | $3.25M | Sell |
35,359
-2,696
| -7% | -$243K | 0.88% | 35 |
|
|
2015
Q4 | $3.85M | Buy |
38,055
+2,311
| +6% | +$240K | 1% | 18 |
|
|
2015
Q3 | $3.51M | Buy |
35,744
+3,155
| +10% | +$350K | 0.91% | 21 |
|
|
2015
Q2 | $3.81M | Buy |
32,589
+3,649
| +13% | +$399K | 1.03% | 16 |
|
|
2015
Q1 | $2.84M | Buy |
28,940
+28,480
| +6,191% | +$2.89M | 0.7% | 46 |
|
|
2014
Q4 | $43K | Sell |
460
-150
| -25% | -$15.5K | 0.01% | 415 |
|
|
2014
Q3 | $65K | Buy |
610
+150
| +33% | +$14.7K | 0.02% | 373 |
|
|
2014
Q2 | $38K | Buy |
460
+40
| +10% | +$3.11K | 0.01% | 426 |
|
|
2014
Q1 | $30K | Buy |
420
+395
| +1,580% | +$31K | 0.01% | 435 |
|
|
2013
Q4 | $2K | Hold |
25
| – | – | ﹤0.01% | 756 |
|
|
2013
Q3 | $2K | Buy |
25
+5
| +25% | +$299 | ﹤0.01% | 793 |
|
|
2013
Q2 | $1K | Buy |
+20
| New | +$1.04K | ﹤0.01% | 841 |
|
Other funds holding GILD
Regal Investment Advisors's GILD Position: Q2 2026 in Review
Regal Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,573 shares — an estimated $219K sold.
Regal Investment Advisors first reported a position in GILD in Q2 2013 and held it in 36 quarters. The position peaked at $3.85M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Regal Investment Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Regal Investment Advisors sold 1,573 Gilead Sciences shares in Q2 2026, an estimated $219K.
- Regal Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 36 quarters.
- Regal Investment Advisors's Gilead Sciences position peaked at $3.85M in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Regal Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.